RU94042516A - Method of opium abstinent syndrome arresting - Google Patents

Method of opium abstinent syndrome arresting

Info

Publication number
RU94042516A
RU94042516A RU94042516/14A RU94042516A RU94042516A RU 94042516 A RU94042516 A RU 94042516A RU 94042516/14 A RU94042516/14 A RU 94042516/14A RU 94042516 A RU94042516 A RU 94042516A RU 94042516 A RU94042516 A RU 94042516A
Authority
RU
Russia
Prior art keywords
arresting
opium
period
reduce
drug
Prior art date
Application number
RU94042516/14A
Other languages
Russian (ru)
Other versions
RU2131245C1 (en
Inventor
С.И. Жижилев
Original Assignee
С.И. Жижилев
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by С.И. Жижилев filed Critical С.И. Жижилев
Priority to RU94042516A priority Critical patent/RU2131245C1/en
Publication of RU94042516A publication Critical patent/RU94042516A/en
Application granted granted Critical
Publication of RU2131245C1 publication Critical patent/RU2131245C1/en

Links

Abstract

FIELD: medicine, narcology. SUBSTANCE: method involves intramuscular administration of complex drug consisting of 5% pentamine, 50% analgin, 1% dimedrol and relanium. Together with medicinal treatment suggestive action is carried out in patient to stop narcotic uptake. EFFECT: decreased arresting time, decreased relapse, prolonged remission.

Claims (1)

Изобретение относится к медицине, а именно к наркологии и может быть использовано для лечения больных наркоманией. Заявляемый способ включает внутримышечное введение комплекса лекарственных препаратов, в состав которых входит пентамин 5%, анальгин 50%, димедроль 1% и реланиум. Совместно с лекарственным воздействием осуществляют суггестивное, направленное на формирование у больного психологической установки на прекращение приема наркотиков. Способ позволяет сократить срок купирования абстинентного синдрома, уменьшить вероятность рецидива приема наркотиков, продлить период ремиссии.The invention relates to medicine, namely to narcology and can be used to treat patients with drug addiction. The inventive method includes intramuscular administration of a complex of drugs, which include pentamine 5%, analgin 50%, diphenhydramine 1% and relanium. Together with the drug exposure, a suggestive one is carried out, aimed at forming a patient's psychological attitude to stop taking drugs. The method allows to reduce the period of relief of withdrawal symptoms, reduce the likelihood of a relapse of drug use, extend the period of remission.
RU94042516A 1994-12-05 1994-12-05 Method of stopping opium abstinent syndrome RU2131245C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94042516A RU2131245C1 (en) 1994-12-05 1994-12-05 Method of stopping opium abstinent syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94042516A RU2131245C1 (en) 1994-12-05 1994-12-05 Method of stopping opium abstinent syndrome

Publications (2)

Publication Number Publication Date
RU94042516A true RU94042516A (en) 1996-11-10
RU2131245C1 RU2131245C1 (en) 1999-06-10

Family

ID=20162763

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94042516A RU2131245C1 (en) 1994-12-05 1994-12-05 Method of stopping opium abstinent syndrome

Country Status (1)

Country Link
RU (1) RU2131245C1 (en)

Also Published As

Publication number Publication date
RU2131245C1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
PT97552A (en) METHOD FOR PREPARING FORMS OF DOSAGE FOR THE ADMINISTRATION OF DRUGS FOR THE TREATMENT OF PARKISON'S DISEASE
KR950703951A (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
NO306377B1 (en) Dosage form for delivery of a drug
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE3780819T2 (en) QUATERNAERE DERIVATIVES OF NOROXYMORPHONE FOR THE TREATMENT OF Nausea AND Vomiting.
RU2002124141A (en) APPLICATION OF MIRTAZAPINE FOR TREATMENT OF SLEEP DISORDERS
RU94042516A (en) Method of opium abstinent syndrome arresting
Neill Postoperative analgesia following brachial plexus block
SE9101341D0 (en) NEW MEDICINAL USE
SU429813A1 (en) METHOD OF TREATING PULMONARY TUBERCULOSIS
SE8804640L (en) MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
SE9903985D0 (en) Use of nitric oxide
RU2001113211A (en) METHOD FOR TREATMENT OF ACUTE ABSTINENT SYNDROME OF PATIENTS WITH ADDICTION
RU94000695A (en) Agent showing antiallergic action
RU99107874A (en) METHOD FOR TREATING ABSTINENT SYNDROME IN PATIENTS WITH HEROIN ADDICTION
Kaufman et al. Overdose treatment: addict folklore and medical reality
RU2147880C1 (en) Drug for treatment of patients with chronic alcoholism and method of their treatment
US6030631A (en) Device and method for decreasing nausea and vomiting
RU2002105074A (en) METHOD FOR TREATING AND PREVENTING THE DEVELOPMENT OF HYPERTROPHIC AND KELOID SCARS
Sorensen et al. Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone
EA200001014A3 (en) Medicament for treating patients suffering from opiomania and method therefor
SU1205915A1 (en) Method of treatment of allergic diseases
RU2152211C1 (en) Method of treatment of patients with eczema
RU2002129097A (en) COMBINED THERAPIES USING VASCULAR HARMFUL ACTIVITY
Friedman Pain patients just say ‘no’to drug addiction